Following the confirmation of a category A disease in an establishment with kept animals of listed species, Article 26 of Delegated Regulation (EU) 2020/687 requires that official veterinarians carry out visits to the establishments located in the protection zone. The scope of these visits is to perform the necessary checks and examinations, including sampling for laboratory testing, to detect early the possible spread of the category A disease to other establishments in that zone. The procedures for the taking of samples at the establishments to be visited, and for the clinical and laboratory examinations in the visited establishments, are laid down in Annex I to Delegated Regulation (EU) 2020/687. The clinical and laboratory examinations of animals of listed species kept in establishments located in the protection zone are also required by Article 39(1), point (b), of that Delegated Regulation. Since the adoption of Delegated Regulation (EU) 2020/687, the European Food Safety Authority (EFSA) has issued, in 2021 and 2022, scientific opinions on the assessment of the effectiveness of control measures for each category A disease [Scientific Opinion on the assessment of the control measures for category A diseases of Animal Health Law: Foot and Mouth Disease, https://efsa.onlinelibrary.wiley.com/doi/epdf/10.2903/j.efsa.2021.6632. Assessment of the control measures of category A diseases of the Animal Health Law: Infection with rinderpest virus (Rinderpest), https://efsa.onlinelibrary.wiley.com/doi/epdf/10.2903/j.efsa.2022.7071. Assessment of the control measures of the category A diseases of Animal Health Law: Rift Valley Fever, https://www.efsa.europa.eu/en/efsajournal/pub/7070. Assessment of the control measures for category A diseases of Animal Health Law: Lumpy Skin Disease, https://www.efsa.europa.eu/en/efsajournal/pub/7121. Assessment of the control measures for category A diseases of Animal Health Law: Contagious Bovine Pleuropneumonia, https://www.efsa.europa.eu/en/efsajournal/pub/7067. Assessment of the control measures of the category A diseases of Animal Health Law: sheep and goat pox, https://www.efsa.europa.eu/en/efsajournal/pub/6933. Assessment of the control measures of the category A diseases of Animal Health Law: peste des petits ruminants, https://www.efsa.europa.eu/en/efsajournal/pub/6708. Assessment of the control measures for category A diseases of Animal Health Law: Contagious Caprine Pleuropneumonia, https://www.efsa.europa.eu/en/efsajournal/pub/7068. Assessment of the control measures of the category A diseases of Animal Health Law: Classical Swine Fever, https://www.efsa.europa.eu/en/efsajournal/pub/6707. Scientific Opinion on the assessment of the control measures of the category A diseases of Animal Health Law: African Swine Fever, https://www.efsa.europa.eu/en/efsajournal/pub/6402. Assessment of the control measures of the category A diseases of Animal Health Law: Burkholderia mallei (Glanders), https://www.efsa.europa.eu/en/efsajournal/pub/7069. Scientific Opinion on the assessment of the control measures of the category A diseases of Animal Health Law: African Horse Sickness, https://www.efsa.europa.eu/en/efsajournal/pub/6403. Scientific Opinion on the assessment of the control measures of the category A diseases of Animal Health Law: Highly Pathogenic Avian Influenza, https://www.efsa.europa.eu/en/efsajournal/pub/6372. Assessment of the control measures of the category A diseases of Animal Health Law: Newcastle disease, https://www.efsa.europa.eu/en/efsajournal/pub/6946.] (the relevant scientific evidence) including recommended clinical and laboratory examinations and sampling procedures to detect those diseases. Therefore, Article 26(2), point (d), and Article 39(1), point (b), of Delegated Regulation (EU) 2020/687 should be amended to refer to the need to collect samples for laboratory examinations when the relevant scientific evidence recommends such measures. In addition, Annex I to Delegated Regulation (EU) 2020/687 should be amended to add the requirement that the sampling procedures laid down in point A of that Annex must be based on the relevant scientific evidence for the respective category A disease.
Recital 9, Regulation (EU) 2026/322
In forcesince 12 Feb 2026